Raymond Tzer Pin T P Lin

Dr. Raymond Tzer Pin T P Lin

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAnderson F. Brito
Anderson F. Brito
ESElizaveta Semenova
Elizaveta Semenova
GDGytis Dudas
Gytis Dudas
GHGabriel W. Hassler
Gabriel W. Hassler
CKChaney C. Kalinich
Chaney C. Kalinich
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness, and efforts must be made to support low- and middle-income countries improve their local sequencing capacity.

26 August 2022 in Science
Verified
Journal Article
Open access
JPJonathan E. Pekar
Jonathan E. Pekar
AMAndrew Magee
Andrew Magee
EPEdyth Parker
Edyth Parker
Niema MoshiriNiema Moshiri
Niema Moshiri
KIKatherine Izhikevich
Katherine Izhikevich
JWJoel O. Wertheim
Joel O. Wertheim
Understanding the circumstances that lead to pandemics is important for their prevention. We analyzed the genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the coronavirus disease 2019 (COVID-19) pandemic. We show that SARS-CoV-2 genomic diversity before February 2020 likely comprised only two distinct viral lineages, denoted “A” and “B.” Phylodynamic rooting methods, coupled with epidemic simulations, reveal that these lineages were most probably the result of at least two separate cross-species transmission events into humans. The first zoonotic transmission likely involved lineage B viruses around 18 November 2019 (23 October to 8 December), and the separate introduction of lineage A likely occurred within weeks of this event. These findings indicate that it is unlikely that SARS-CoV-2 circulated widely in humans before November 2019 and define the narrow window between when SARS-CoV-2 first jumped into humans and when the first cases of COVID-19 were reported. As with other coronaviruses, SARS-CoV-2 emergence likely resulted from multiple zoonotic events.

1 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KMKalisvar Marimuthu
Kalisvar Marimuthu
IVIndumathi Venkatachalam
Indumathi Venkatachalam
VKVanessa Koh
Vanessa Koh
SHStephan Harbarth
Stephan Harbarth
EPEli Perencevich
Eli Perencevich
CGCarbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) Study Group
Carbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) Study Group
Carbapenemase-producing Enterobacterales (CPE) infection control practices are based on the paradigm that detected carriers in the hospital transmit to other patients who stay in the same ward. The role of plasmid-mediated transmission at population level remains largely unknown. In this retrospective cohort study over 4.7 years involving all multi-disciplinary public hospitals in Singapore, we analysed 779 patients who acquired CPE (1215 CPE isolates) detected by clinical or surveillance cultures. 42.0% met putative clonal transmission criteria, 44.8% met putative plasmid-mediated transmission criteria and 13.2% were unlinked. Only putative clonal transmissions associated with direct ward contact decreased in the second half of the study. Both putative clonal and plasmid-mediated transmission associated with indirect (no temporal overlap in patients’ admission period) ward and hospital contact did not decrease during the study period. Indirect ward and hospital contact were identified as independent risk factors associated with clonal transmission. In conclusion, undetected CPE reservoirs continue to evade hospital infection prevention measures. New measures are needed to address plasmid-mediated transmission, which accounted for 50% of CPE dissemination.

26 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ABAnderson F. Brito
Anderson F. Brito
ESElizaveta Semenova
Elizaveta Semenova
GDGytis Dudas
Gytis Dudas
GHGabriel W. Hassler
Gabriel W. Hassler
CKChaney Kalinich
Chaney Kalinich
MKMaria van Kerkhove
Maria van Kerkhove
The COVID-19 pandemic has revealed the importance of virus genome sequencing to guide public health interventions to control virus transmission and understand SARS-CoV-2 evolution. As of July 20th, 2021, >2 million SARS-CoV-2 genomes have been submitted to GISAID, 94% from high income and 6% from low and middle income countries. Here, we analyse the spatial and temporal heterogeneity in SARS-CoV-2 global genomic surveillance efforts. We report a comprehensive analysis of virus lineage diversity and genomic surveillance strategies adopted globally, and investigate their impact on the detection of known SARS-CoV-2 virus lineages and variants of concern. Our study provides a perspective on the global disparities surrounding SARS-CoV-2 genomic surveillance, their causes and consequences, and possible solutions to maximize the impact of pathogen genome sequencing for efforts on public health. One-Sentence Summary The causes, consequences and possible solutions for disparities in genomic surveillance observed in the COVID-19 pandemic.

8 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LRLaurent Renia
Laurent Renia
YGYun Shan Goh
Yun Shan Goh
ARAngeline Rouers
Angeline Rouers
NBNina Le Bert
Nina Le Bert
WCWan Ni Chia
Wan Ni Chia
LNLisa F.P. Ng
Lisa F.P. Ng
Understanding the impact of age on vaccinations is essential for the design and delivery of vaccines against SARS-CoV-2. Here, we present findings from a comprehensive analysis of multiple compartments of the memory immune response in 312 individuals vaccinated with the BNT162b2 SARS-CoV-2 mRNA vaccine. Two vaccine doses induce high antibody and T cell responses in most individuals. However, antibody recognition of the Spike protein of the Delta and Omicron variants is less efficient than that of the ancestral Wuhan strain. Age-stratified analyses identify a group of low antibody responders where individuals ≥60 years are overrepresented. Waning of the antibody and cellular responses is observed in 30% of the vaccinees after 6 months. However, age does not influence the waning of these responses. Taken together, while individuals ≥60 years old take longer to acquire vaccine-induced immunity, they develop more sustained acquired immunity at 6 months post-vaccination. A third dose strongly boosts the low antibody responses in the older individuals against the ancestral Wuhan strain, Delta and Omicron variants.

30 May 2013 in Virology Journal
Verified
Journal Article
Open access
PDF file
KCKaren Caiyun Chen
Karen Caiyun Chen
Yiu Wing Jason KAMYiu Wing Jason KAM
Yiu Wing Jason KAM
RLRaymond Tzer Pin T P Lin
Raymond Tzer Pin T P Lin
MNMary Mah-Lee Ng
Mary Mah-Lee Ng
LNLisa F.P. Ng
Lisa F.P. Ng
Justin Jang Hann CHUJustin Jang Hann CHU
Justin Jang Hann CHU
Background: A comparative analysis of the genomic and replication profiles of different geographical chikungunya virus (CHIKV) isolates of the East, Central and South African (ECSA) lineage was performed. Findings: Analysis of the data revealed the different growth kinetics for the different isolates. Deep genome sequencing analysis further revealed specific amino acid mutations in the viral nsP1, nsP3, nsP4, E1 and E2 proteins in the different isolates. Despite the difference in viral genomic profiles, the virus-induced ultrastructural changes within infected cells remained highly conserved among the different chikungunya virus isolates. Conclusions: These findings provide insights into the genomic and replication profiles of the re-emerging chikungunya virus isolates of the ECSA lineage.